Medical Properties Trust, Inc. (MPW)

Medical Properties Trust Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Medical Properties Trust stock have an average target of 5.64, with a low estimate of 4.00 and a high estimate of 9.00. The average target predicts an increase of 3.30% from the current stock price of 5.46.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$4.00	$5.64	$5.00	$9.00
Change	-26.74%	+3.30%	-8.42%	+64.84%

* Price targets were last updated on Mar 12, 2025.

Analyst Ratings

The average analyst rating for Medical Properties Trust stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	1	1
Hold	7	6	6	6	4	4
Sell	2	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	10	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Nate Crossett Exane BNP Paribas	Exane BNP Paribas	Hold → Buy Upgrades $5 → $9	Hold → Buy	Upgrades	$5 → $9	+64.84%	Mar 12, 2025
Michael Carroll RBC Capital	RBC Capital	Hold Maintains $4 → $5	Hold	Maintains	$4 → $5	-8.42%	Mar 10, 2025
Connor Siversky Wells Fargo	Wells Fargo	Sell Maintains $4 → $5	Sell	Maintains	$4 → $5	-8.42%	Mar 10, 2025
Michael Lewis Truist Securities	Truist Securities	Hold Maintains $6 → $4	Hold	Maintains	$6 → $4	-26.74%	Dec 19, 2024
Vikram Malhotra Mizuho	Mizuho	Hold Maintains $6 → $5	Hold	Maintains	$6 → $5	-8.42%	Dec 5, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

937.06M

Decreased by -9.78%

from 1.04B

Revenue Next Year

1.01B

Increased by 7.78%

from 937.06M

EPS This Year

-0.07

from -4.02

EPS Next Year

-0.03

from -0.07

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.27B	1.57B	1.58B	885.77M	1.04B	937.06M	1.01B	1.11B
Revenue Growth	45.90%	23.90%	0.67%	-44.07%	17.27%	-9.78%	7.78%	10.20%
EPS	0.81	1.11	1.50	-0.93	-4.02	-0.07	-0.03	0.25
EPS Growth	-6.90%	37.04%	35.14%	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	21.62
No. Analysts	-	-	-	-	-	7	7	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.1B	1.2B	1.2B
Avg	937.1M	1.0B	1.1B
Low	799.1M	847.2M	1.1B

Revenue Growth

Revenue Growth	2025	2026	2027
High	10.5%	22.9%	14.6%
Avg	-9.8%	7.8%	10.2%
Low	-23.1%	-9.6%	6.8%

EPS Forecast

EPS	2025	2026	2027
High	0.22	0.27	0.26
Avg	-0.07	-0.03	0.25
Low	-0.47	-0.70	0.25

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.